Price $2.06 |
Market Cap
19.9M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
24.52
|
P/S
42.31
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-3.5K
|
FCF
-0.4
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-
|
ROI
-554.70%
|
|
ROA
-590.60%
|
EPS Growth
-41.70%
|
Current Ratio
2.7
|
Debt/Equity
71.40%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Biostar Pharmaceuticals Inc (BSPM) | $1.45 | - | - | 4M | Strong Buy |
| Aralez Pharmaceuticals Inc (ARLZ) | $1.43 | - | - | 91.5M | Strong Buy |
| Momenta Pharmaceuticals, Inc. (MNTA) | $16.80 | - | - | 1.27B | Strong Buy |
| CRYO-CELL International, Inc. (CCEL) | $6.50 | - | - | 43M | Strong Buy |
| RTI Surgical Inc (RTIX) | $5.60 | - | - | 342.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
